Experimental therapies in preclinical tumor models : validiating PI3K inhibitors and sulfasalazine in cancer treatment
Hilde Elise Førde-TislevollFørde-Tislevoll, Hilde Elise Bok Engelsk utgitt 2016
Ledig
- Automatlager: 3 av 3 ledig
*001619434 *00520190107202025.0 *007ta *008161117s2016 no a e m 00 0 eng *00901015nam a2200265 c 4500 *019 $bl *020 $a978-82-308-3212-7$qh. *035 $a(EXLNZ-47BIBSYS_NETWORK)999920190570602201 *035 $a(NO-LaBS)13502065(bibid) *040 $aNO-OsNB$bnob$ekatreg *060 4$aQZ 266 *08204$a616.994060724$223/nor$qNO-OsNB *1001 $aFørde-Tislevoll, Hilde Elise$d1985-$0(NO-TrBIB)10046903$4aut$_91012400 *24510$aExperimental therapies in preclinical tumor models :$bvalidiating PI3K inhibitors and sulfasalazine in cancer treatment$cHilde Elise Førde-Tislevoll *260 $a[Bergen]$bUniversity of Bergen$c2016 *300 $a1 b. (flere pag.)$bill. (noen kol.)$c24 cm *500 $aDelvis opptrykk av artikler *502 $aAvhandling (ph.d.) - Universitetet i Bergen, 2016 *650 2$aBrain Neoplasms$0D001932$_75512800 *650 2$aGlioblastoma$0D005909$_19034800 *650 2$aNeoplasms$0D009369$_22109500 *7102 $aUniversitetet i Bergen$bInstitutt for biomedisin$0(NO-TrBIB)10073621$4dgg$_12926500 *913 $aNorbok$bNB *917 $ad *999 $aoai:nb.bibsys.no:999919859991302202$b2021-11-14T20:36:22Z$z999919859991302202 ^